The negligible contribution of the NLRP3 inflammasome to stroke-induced brain injury, may in part, explain why Tet2-mediated CH did not worsen ischemic stroke outcomes in the current study. The gene discussed is NLRP3; the disease is cyclic hematopoiesis.